Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Open-label exploratory study to evaluate the effect of dupilumab on skin barrier function in pediatric patients with moderate to severe atopic dermatitis

Next Previous
X
Search
Trial Profile

Open-label exploratory study to evaluate the effect of dupilumab on skin barrier function in pediatric patients with moderate to severe atopic dermatitis

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 09 May 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dupilumab (Primary)
  • Indications Atopic dermatitis
  • Focus Therapeutic Use
  • Acronyms PELISTAD
  • Sponsors Sanofi

    • Most Recent Events

    • 12 Mar 2024 Results assessing impact of dupilumab treatment on skin barrier function and stratum corneum (SC) lipid components in children with moderate-to-severe atopic dermatitis , presented at the American Academy of Dermatology annual Meeting 2024
    • 12 Mar 2024 Primary endpoint has been met (Percent Change From Baseline in Transepidermal Water Loss (TEWL) After 5 Skin Tape Stripping (STS) on Lesional Skin (LS) in AD Participants at Week 16) , according to Results presented at the American Academy of Dermatology annual Meeting 2024
    • 12 Mar 2024 Results assessing skin barrier function, clinical outcomes, and patient-reported outcomes presented at the American Academy of Dermatology annual Meeting 2024

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top